Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A Risk Prediction and Clinical Guidance System for Evaluating Patients with Recurrent Infections

View ORCID ProfileNicholas L. Rider, Gina Cahill, Tina Motazedi, Lei Wei, Ashok Kurian, Lenora M. Noroski, View ORCID ProfileFiliz O. Seeborg, View ORCID ProfileIvan K. Chinn, View ORCID ProfileKirk Roberts
doi: https://doi.org/10.1101/2020.06.12.20129692
Nicholas L. Rider
1Baylor College of Medicine, Houston, TX (USA)
2Section of Immunology, Allergy and Retrovirology, Texas Children’s Hospital, Houston, TX (USA)
3Department of Information Services, Texas Children’s Hospital, Houston, TX (USA)
DO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nicholas L. Rider
  • For correspondence: nlrider{at}bcm.edu
Gina Cahill
1Baylor College of Medicine, Houston, TX (USA)
2Section of Immunology, Allergy and Retrovirology, Texas Children’s Hospital, Houston, TX (USA)
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tina Motazedi
1Baylor College of Medicine, Houston, TX (USA)
4Massachusetts General Hospital, Boston, MA (USA)
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lei Wei
3Department of Information Services, Texas Children’s Hospital, Houston, TX (USA)
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashok Kurian
3Department of Information Services, Texas Children’s Hospital, Houston, TX (USA)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lenora M. Noroski
1Baylor College of Medicine, Houston, TX (USA)
2Section of Immunology, Allergy and Retrovirology, Texas Children’s Hospital, Houston, TX (USA)
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Filiz O. Seeborg
1Baylor College of Medicine, Houston, TX (USA)
2Section of Immunology, Allergy and Retrovirology, Texas Children’s Hospital, Houston, TX (USA)
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Filiz O. Seeborg
Ivan K. Chinn
1Baylor College of Medicine, Houston, TX (USA)
2Section of Immunology, Allergy and Retrovirology, Texas Children’s Hospital, Houston, TX (USA)
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ivan K. Chinn
Kirk Roberts
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kirk Roberts
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Primary immunodeficiency diseases represent an expanding set of heterogeneous conditions which are difficult to recognize clinically. Diagnostic rates outside of the newborn period have not changed appreciably. This concern underscores a need for novel methods of disease detection.

Objective We built an artificial intelligence model to provide real-time risk assessment about primary immunodeficiency and to facilitate prescriptive analytics for initiating the most appropriate diagnostic work up. Our goal is to improve diagnostic rates for primary immunodeficiency and shorten time to diagnosis.

Methods We extracted data from the Texas Children’s Hospital electronic health record on a large population of primary immunodeficiency patients (n = 1762) and age-matched set of controls (n = 1698). From the cohorts, clinically relevant prior probabilities were calculated enabling construction of a Bayesian network probabilistic model. Our model was constructed with clinical-immunology domain expertise, trained on a balanced cohort of 100 cases-controls and validated on an unseen balanced cohort of 150 cases-controls. Performance was measured by area under the receiver operator characteristic curve (AUROC).

Results Our Bayesian network was accurate in classifying immunodeficiency patients from controls (AUROC = 0.945; p<0.0001) at a risk threshold of ≥6%. Additionally, the model was 89% accurate for categorizing validation cohort members into appropriate International Union of Immunological Societies diagnostic categories.

Conclusion Artificial intelligence methods can classify risk for primary immunodeficiency and guide management. Our Bayesian network enables highly accurate, objective decision making about risk and guides the user towards the appropriate diagnostic evaluation for patients with recurrent infections.

Competing Interest Statement

NLR received consulting fees for scientific advisory activities with Takeda Pharmaceuticals Horizon Therapeutics and CSL Behring. He also receives royalties from Wolters Kluwer for topic contribution to UpToDate. All other authors have nothing to disclose.

Funding Statement

This work was funded through a Translational Research Grant (Award No - 58293-I) by the Jeffrey Modell Foundation

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the Baylor College of Medicine Institutional Review Board (H-38501). All patient data remained confidential and was retained in the Texas Childrens Hospital system.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵† Dr. Motazedi was a resident at Baylor College of Medicine during the majority of her contribution to this work. Presently she is a fellow in training at The Massachusetts General Hospital.

Data Availability

Patient protected health information (PHI) is not available; however, all clinical data used to generate inference by the Bayesian network is available. Most relevant data from our study are included in the supplementary materials. Additional data availability may be made available from the corresponding author on reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 13, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A Risk Prediction and Clinical Guidance System for Evaluating Patients with Recurrent Infections
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A Risk Prediction and Clinical Guidance System for Evaluating Patients with Recurrent Infections
Nicholas L. Rider, Gina Cahill, Tina Motazedi, Lei Wei, Ashok Kurian, Lenora M. Noroski, Filiz O. Seeborg, Ivan K. Chinn, Kirk Roberts
medRxiv 2020.06.12.20129692; doi: https://doi.org/10.1101/2020.06.12.20129692
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
A Risk Prediction and Clinical Guidance System for Evaluating Patients with Recurrent Infections
Nicholas L. Rider, Gina Cahill, Tina Motazedi, Lei Wei, Ashok Kurian, Lenora M. Noroski, Filiz O. Seeborg, Ivan K. Chinn, Kirk Roberts
medRxiv 2020.06.12.20129692; doi: https://doi.org/10.1101/2020.06.12.20129692

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Allergy and Immunology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)